| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| AROCLOR 1254 | TOX-Non-Repro-Sublethal - organ/system effects | thyroid wt/body wt and liver wt/body wt ratios versus controls | increased @ 100, 250, 500 mg/kg bw | 6-12/dose | Adult | 5 wks | Toxicity Factor Datasets |
| AROCLOR 1254 | TOX-EXP IND - biomarkers | hepatic microsomal EROD and PROD activities versus controls | increased @ 20,100, 250, 500 mg/kg bw | 6-12/dose | Adult | 5 wks | Toxicity Factor Datasets |
| AROCLOR 1254 | TOX-Non-Repro-Sublethal - organ/system effects | plasma triiodothyronine concentrations versus controls | decreased @ 20, 100, 250, 500 mg/kg bw | 6-12/dose | Adult | 5 wks | Toxicity Factor Datasets |
| AROCLOR 1254 | TOX-Non-Repro-Sublethal - organ/system effects | leukocyte counts, plasma biochemistry, corticosterone concentration versus controls | no effect | 6-12/dose | Adult | 5 wks | Toxicity Factor Datasets |
| AROCLOR 1254 | TOX-Non-Repro-Sublethal - organ/system effects | lymphocyte proliferation to PHA versus controls | increased @ 250, 500 mg/kg bw | 6-12/dose | Adult | 5 wks | Toxicity Factor Datasets |
